Predicting potential therapeutic targets and small molecule drugs for early-stage lung adenocarcinoma

Predicting potential therapeutic targets and small molecule drugs for early-stage lung adenocarcinoma

Lung cancer is a leading cause of cancer-related mortality worldwide, with non-small cell lung cancer (NSCLC) constituting the majority, and its main subtype being lung adenocarcinoma (LUAD). Despite substantial advances in LUAD diagnosis and treatment, early diagnostic biomarkers inadequately fulfi...

Full description

Bibliographic Details
Main Authors: Yongxin Yu, Lingchen Li, Bangyu Luo, Diangang Chen, Chenrui Yin, Chunli Jian, Qiai You, Jianmin Wang, Ling Fang, Dingqin Cai, Jianguo Sun
Format: Article
Language:English
Published: Elsevier 2024-05-01
Series:Biomedicine & Pharmacotherapy
Subjects:
LUAD
bioinformatics analysis
molecular docking
biomarker
Aminopurvalanol A
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332224004128

Similar Items

Similar Items